These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19210687)

  • 1. Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients.
    Pons JA; Ramírez P; Revilla-Nuin B; Pascual D; Baroja-Mazo A; Robles R; Sanchez-Bueno F; Martinez L; Parrilla P
    Clin Transplant; 2009; 23(3):329-36. PubMed ID: 19210687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA; Gimson AE; Gibbs P; Alexander GJ
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
    Ramos-Cebrián M; Torregrosa JV; Gutiérrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplant Proc; 2007 Sep; 39(7):2251-3. PubMed ID: 17889154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
    Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE
    J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
    Tumgor G; Arikan C; Kilic M; Aydogdu S
    Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
    Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation.
    Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM
    Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation.
    Guckelberger O; Bechstein WO; Neuhaus R; Luesebrink R; Lemmens HP; Kratschmer B; Jonas S; Neuhaus PL
    Clin Transplant; 1997 Feb; 11(1):60-5. PubMed ID: 9067697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine C2 monitoring improves renal dysfunction after lung transplantation.
    Glanville AR; Morton JM; Aboyoun CL; Plit ML; Malouf MA
    J Heart Lung Transplant; 2004 Oct; 23(10):1170-4. PubMed ID: 15477111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
    Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
    Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
    Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal outcome after ciclosporin-induced nephrotoxicity.
    Tostivint I; du Montcel ST; Jaudon MC; Mallet A; Le Hoang P; Bodaghi B; Deray G; Bagnis CI
    Nephrol Dial Transplant; 2007 Mar; 22(3):880-5. PubMed ID: 17127700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic renal dysfunction following liver transplantation.
    Schmitz V; Laudi S; Moeckel F; Puhl G; Stockmann M; Tran ZV; Kahl A; Neumann U; Neuhaus P
    Clin Transplant; 2008; 22(3):333-40. PubMed ID: 18341597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful steroid withdrawal in lung transplant recipients: result of a pilot study.
    Shitrit D; Bendayan D; Sulkes J; Bar-Gil Shitrit A; Huerta M; Kramer MR
    Respir Med; 2005 May; 99(5):596-601. PubMed ID: 15823457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function in pediatric liver transplantation: a long-term follow-up study.
    Harambat J; Ranchin B; Dubourg L; Liutkus A; Hadj-Haïssa A; Rivet C; Boillot O; Lachaux A; Cochat P
    Transplantation; 2008 Oct; 86(8):1028-34. PubMed ID: 18946339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications.
    Miozzari M; Ambühl PM
    Nephrol Dial Transplant; 2004 Oct; 19(10):2615-21. PubMed ID: 15280521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
    Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
    Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionised and total serum magnesium in renal transplant patients.
    Mazzaferro S; Barberi S; Scarda A; Pasquali M; Rubino F; D'Erasmo E
    J Nephrol; 2002; 15(3):275-80. PubMed ID: 12113599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome after cyclosporine dose reduction based on C2 levels in long-term liver transplant patients.
    Tha-In T; Hesselink DA; Tilanus HW; Elshove L; Wilschut AL; Hansen BE; van Gelder T; Metselaar HJ
    Clin Transplant; 2005 Aug; 19(4):537-42. PubMed ID: 16008602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety of cyclosporine in the treatment of psoriasis.
    Grossman RM; Chevret S; Abi-Rached J; Blanchet F; Dubertret L
    Arch Dermatol; 1996 Jun; 132(6):623-9. PubMed ID: 8651712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.